摘要
对国内外药品(化学药、生物制品及植物药)上市许可的稳定性指标选择及结果评价进行梳理,并对药品上市后有关变更事项中的稳定性要求及有效期确定进行分析。参照中药现有的稳定性研究技术要求,对中药稳定性研究在试验设计、稳定性结果判断指标、标准及有效性设定等方面提出建议,以期为中药稳定性研究、审评及稳定性指导原则的修订提供参考。
The present study summarized the stability indicators and evaluation of medicinal products available(chemical drugs,biological products,and botanical products) in the stage of marketing authorization,and analyzed the stability requirements and validity period determination throughout the relevant post-marketing changes stages.With reference to the existing technical requirements for the research on the stability of Chinese medicine,we offer suggestions on test design,criteria or indicators used in stability evaluation,shelf life determination of Chinese medicine determination of Chinese medicine to provide references for the stability research and review and revision of stability guidelines of Chinese medicine.
作者
关宏峰
赵晓霞
唐溱
张永文
GUAN Hong-feng;ZHAO Xiao-xia;TANG Zhen;ZHANG Yong-wen(Center for Drug Evaluation,National Medical Products Administration,Beijing 100022,China;College of Pharmacy,Nanjing University of Chinese Medicine,Nanjing 210023,China)
出处
《中国现代中药》
CAS
2022年第6期1139-1143,共5页
Modern Chinese Medicine
关键词
中药
稳定性研究
试验设计
质量标准
结果评价
Chinese medicine
stability research
test design
quality standard
result assessment